Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine for Liver Cirrhosis in Chronic Hepatitis B
NCT01380951Phase 4Unknown
- Sponsor
- Suzhou Fifth People's Hospital
- Start
- May 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Suzhou Fifth People's Hospital. Status: unknown.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01380951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01380951.